Boston is the top biotech cluster in the world based on the number and amount of initial public offerings by biotech firms based in the region this year, Luke Timmerman writes. Eight biotech companies in Boston raised a total of $769.6 million, followed by the New York/New Jersey region, which had eight IPOs worth $668.2 million. Rounding out the top 10 were San Diego; the San Francisco Bay Area; North Carolina; Israel; Maryland/Washington, D.C.; Pennsylvania; Texas; and the Netherlands.

Full Story:

Related Summaries